Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Karl Vandepoele

Ghent University Hospital

ORCID iD: 0000-0002-0025-5594

Show Sort by

Add to list
- Journal Article
- A1
- open access
Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm

Sander De Bruyne (UGent) , EVA STEEL (UGent) , Marjan Petrick (UGent) , Barbara Denys (UGent) , Karl Vandepoele (UGent) , Nadine Van Roy (UGent) , Simon Degandt, Timothy Ghys and Henk Louagie (UGent)

(2021) CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 59(10). p.E392-E394
Add to list
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705
Add to list
- Conference Paper
- C3
Clinical significance of TARP expression in pediatric acute myeloid leukemia

B. Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , A. Uyttebroeck, A. Van Damme, B. Denys, L. Dedeken, M. -F. Dresse, J. Van der Werff Ten Bosch, M. Hofmans, et al.

(2020) PEDIATRIC BLOOD & CANCER. 67(Suppl. 4). p.S198-S198
Add to list
- Journal Article
- A1
- open access
Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans (UGent) , et al.

(2020) HEMASPHERE. 4(2).
Add to list
- Journal Article
- A1
- open access
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316
Add to list
- Conference Paper
- C3
Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte Van der Werff Ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) BLOOD. 134(S1). p.1457-1457
Add to list
- Journal Article
- A1
- open access
Standardization of somatic variant classifications in solid and haematological tumours by a two-Level approach of biological and clinical classes : an Initiative of the Belgian ComPerMed Expert Panel

Guy Froyen, Marie Le Mercier, Els Lierman, Karl Vandepoele (UGent) , Friedel Nollet, Elke Boone, Joni Van der Meulen (UGent) , Koen Jacobs, Suzan Lambin, Sara Vander Borght, et al.

(2019) CANCERS. 11(12).
Add to list
- Conference Paper
- C3
- open access
Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter, Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte van der Werff ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) American Society of Hematology, 61st Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
- open access
TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54
Add to list
Clinical implications of measurable residual disease in AML : review of current evidence

Ine Moors (UGent) , Karl Vandepoele (UGent) , Jan Philippé (UGent) , Dries Deeren, Dominik Selleslag, Dimitri Breems, Nicole Straetmans, Tessa Kerre (UGent) and Barbara Denys (UGent)

(2019) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 133. p.142-148

1
2
3
4

Next →